S. Robb

7.8k total citations
94 papers, 4.2k citations indexed

About

S. Robb is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, S. Robb has authored 94 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 35 papers in Neurology and 15 papers in Genetics. Recurrent topics in S. Robb's work include Myasthenia Gravis and Thymoma (29 papers), Muscle Physiology and Disorders (21 papers) and Neurogenetic and Muscular Disorders Research (15 papers). S. Robb is often cited by papers focused on Myasthenia Gravis and Thymoma (29 papers), Muscle Physiology and Disorders (21 papers) and Neurogenetic and Muscular Disorders Research (15 papers). S. Robb collaborates with scholars based in United Kingdom, United States and Italy. S. Robb's co-authors include Caroline A. Sewry, Heinz Jungbluth, Francesco Muntoni, David Beeson, Adnan Y. Manzur, Jacqueline Palace, B. E. Kendall, Sandeep Jayawant, David H. Miller and W. I. McDonald and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Brain.

In The Last Decade

S. Robb

92 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Robb United Kingdom 38 2.0k 1.3k 762 628 599 94 4.2k
William J. Kupsky United States 36 1.4k 0.7× 1.1k 0.8× 389 0.5× 217 0.3× 1.4k 2.4× 132 4.9k
Susan Blasér Canada 49 2.4k 1.2× 1.2k 0.9× 763 1.0× 245 0.4× 1.0k 1.7× 268 7.9k
Anne M. Connolly United States 38 2.6k 1.3× 562 0.4× 833 1.1× 238 0.4× 924 1.5× 132 4.9k
F. Cornelio Italy 39 2.0k 1.0× 1.4k 1.0× 298 0.4× 290 0.5× 414 0.7× 134 4.3k
Diana Rodriguez France 34 2.2k 1.1× 1.0k 0.8× 430 0.6× 337 0.5× 375 0.6× 109 4.1k
Martino Ruggieri Italy 40 1.3k 0.7× 1.5k 1.2× 1.5k 1.9× 346 0.6× 133 0.2× 374 5.5k
Andrew J. Kornberg Australia 31 1.3k 0.7× 1.6k 1.2× 252 0.3× 198 0.3× 390 0.7× 108 4.2k
Lionel Van Maldergem Belgium 41 3.8k 1.9× 321 0.2× 2.1k 2.8× 834 1.3× 526 0.9× 153 6.9k
Virginia Kimonis United States 45 4.2k 2.2× 2.2k 1.6× 2.6k 3.4× 1.5k 2.4× 811 1.4× 194 8.5k
P. Landrieu France 32 1.1k 0.6× 745 0.6× 333 0.4× 258 0.4× 219 0.4× 117 3.2k

Countries citing papers authored by S. Robb

Since Specialization
Citations

This map shows the geographic impact of S. Robb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Robb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Robb more than expected).

Fields of papers citing papers by S. Robb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Robb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Robb. The network helps show where S. Robb may publish in the future.

Co-authorship network of co-authors of S. Robb

This figure shows the co-authorship network connecting the top 25 collaborators of S. Robb. A scholar is included among the top collaborators of S. Robb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Robb. S. Robb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sárközy, Anna, Mário Sá, Deborah Ridout, et al.. (2023). Long-term Natural History of Pediatric Dominant and Recessive RYR1 -Related Myopathy. Neurology. 101(15). e1495–e1508. 4 indexed citations
2.
Samuels, Martin, Jacqueline Palace, David Beeson, et al.. (2023). Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre. Brain Communications. 5(6). fcad299–fcad299. 5 indexed citations
3.
Field, Ella, Helen Walsh, Gabrielle Norrish, et al.. (2022). Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort. Frontiers in Pediatrics. 10. 910660–910660. 5 indexed citations
4.
Vecchio, Domizia, Sithara Ramdas, Pinki Munot, et al.. (2019). Paediatric myasthenia gravis: Prognostic factors for drug free remission. Neuromuscular Disorders. 30(2). 120–127. 24 indexed citations
5.
Brunklaus, Andreas, S. Robb, Rosaline C. M. Quinlivan, et al.. (2016). Vitamin D in corticosteroid-naïve and corticosteroid-treated Duchenne muscular dystrophy: what dose achieves optimal 25(OH) vitamin D levels?. Archives of Disease in Childhood. 101(10). 957–961. 11 indexed citations
6.
Logan, Clare V., Judith Cossins, Pedro M. Rodríguez Cruz, et al.. (2015). Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain. The American Journal of Human Genetics. 97(6). 878–885. 55 indexed citations
7.
Illingworth, Marjorie, Marion Main, Matthew Pitt, et al.. (2014). RYR1-related congenital myopathy with fatigable weakness, responding to pyridostigimine. Neuromuscular Disorders. 24(8). 707–712. 31 indexed citations
8.
Klein, Andrea, et al.. (2014). Congenital Myasthenic Syndrome caused by mutations in DPAGT. Neuromuscular Disorders. 25(3). 253–256. 14 indexed citations
9.
Cossins, Judith, Wei Wei Liu, Katsiaryna Belaya, et al.. (2012). The spectrum of mutations that underlie the neuromuscular junction synaptopathy in DOK7 congenital myasthenic syndrome. Human Molecular Genetics. 21(17). 3765–3775. 50 indexed citations
10.
Burke, Georgina, Andrea Klein, E. Niks, et al.. (2012). Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscular Disorders. 23(2). 170–175. 57 indexed citations
11.
Palace, Jacqueline, Daniel Lashley, Stephen Bailey, et al.. (2011). Clinical features in a series of fast channel congenital myasthenia syndrome. Neuromuscular Disorders. 22(2). 112–117. 27 indexed citations
12.
Maddison, Peter J., J. McConville, Maria Elena Farrugia, et al.. (2010). The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome. Journal of Neurology Neurosurgery & Psychiatry. 82(6). 671–673. 90 indexed citations
13.
Mills, Nikki, David Beeson, A. Aloysius, et al.. (2010). Congenital stridor with feeding difficulty as a presenting symptom of Dok7 congenital myasthenic syndrome. International Journal of Pediatric Otorhinolaryngology. 74(9). 991–994. 30 indexed citations
14.
Cowan, Frances M., et al.. (2008). Perinatal dyskinesia as a presenting feature in Prader Willi Syndrome. European Journal of Paediatric Neurology. 13(4). 350–355. 1 indexed citations
15.
Taylor, Jacqueline, Francesco Muntoni, S. Robb, Victor Dubowitz, & Caroline A. Sewry. (1997). Early onset autosomal dominant myopathy with rigidity of the spine: a possible role for laminin β1?. Neuromuscular Disorders. 7(4). 211–216. 23 indexed citations
16.
Chitty, Lyn S., S. Robb, Carolyn A. Berry, David M. Silver, & M Baraitser. (1996). PEHO or PEHO-like syndrome?. Clinical Dysmorphology. 5(2). 143–152. 22 indexed citations
17.
Clayton‐Smith, Jill, T. Webb, S. Robb, et al.. (1992). Further evidence for dominant inheritance at the chromosome 15q11‐13 locus in familial angelman syndrome. American Journal of Medical Genetics. 44(2). 256–260. 29 indexed citations
18.
Robb, S., Melissa McShane, John Wilson, & J Payan. (1991). Acute Onset Spinal Muscular Atrophy in Siblings. Neuropediatrics. 22(1). 45–46. 3 indexed citations
19.
Malcolm, S, Jill Clayton‐Smith, M. Nichols, et al.. (1991). Uniparental paternal disomy in Angelman's syndrome. The Lancet. 337(8743). 694–697. 252 indexed citations
20.
Robb, S., A. Harden, & Stewart Boyd. (1989). Rett Syndrome: An EEG Study in 52 Girls. Neuropediatrics. 20(4). 192–195. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William J. Kupsky Breakdown of academic impact, for papers by Susan Blasér Breakdown of academic impact, for papers by Anne M. Connolly Breakdown of academic impact, for papers by F. Cornelio Breakdown of academic impact, for papers by Diana Rodriguez Breakdown of academic impact, for papers by Martino Ruggieri Breakdown of academic impact, for papers by Andrew J. Kornberg Breakdown of academic impact, for papers by Lionel Van Maldergem Breakdown of academic impact, for papers by Virginia Kimonis Breakdown of academic impact, for papers by P. Landrieu
Rankless by CCL
2026